β¨ Medicines Consent Notices
4648 NEW ZEALAND GAZETTE No. 196
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Factor II 500 IU, factor IX 500 IU, factor X 500 IU with water for injection 20 mL as diluent | Injection, powder with diluent | CSL Limited, Bioplasma Division, Broadmeadows, Victoria, Australia. Diluent: Pharmacia & Upjohn (Perth) Pty Limited, Bentley, Western Australia, Australia | Prothrombinex-HT |
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 26th day of November 1998.
G. R. BOYD,
Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
g08566
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Mesalazine 1% w/v, 4% w/v | Enema | Tillotts Pharma AG., Ziefen, Switzerland | Asacol Enema |
| Metoprolol succinate 47.5 mg, 95 mg, 190 mg | Tablets, modified release | Astra Pharmaceutical Production AB., SΓΆdertΓ€lje, Sweden | Betaloc CR |
| Bromhexine hydrochloride 1.6 mg/mL | Solution, oral | Boehringer Ingelheim Pharma KG., Biberach an der Riss, Germany and Boehringer Ingelheim France, Reims Cedex, France | Bisolvon Elixir |
| Alendronate sodium 13.05 mg, 52.21 mg equivalent to 10 mg, 40 mg alendronic acid | Tablets | Merck Manufacturing Division, Bo. Sabana Hoyos, Arecibo, Puerto Rico and Merck Sharp & Dohme Italia SpA., Pavia, Italy | Fosamax |
| Ispaghula husk 5.25 mg/dose | Granules, oral | Reckitt & Colman Products Limited, Hull, North Humberside, United Kingdom | Fybogest Forte Orange, Fybogest Forte Regular |
| Ispaghula husk 5.25 mg/dose | Granules, oral | Reckitt & Colman Products Limited, Hull, North Humberside, United Kingdom | Fybogest Orange, Fybogest Regular |
| Ispaghula husk 3.5 mg/dose | Granules, oral | Reckitt & Colman Products Limited, Hull, North Humberside, United Kingdom | Fybogest Regular |
| Somatropin 0.2 mg, 0.4 mg, 0.6 mg, 0.8 mg, 1 mg, 1.2 mg, 1.4 mg, 1.6 mg, 1.8 mg, 2 mg | Injection with diluent | Vetter Pharma-Fertigung GmbH & Co Kg., Ravensburg, Germany and Recip AB., Stockholm, Sweden | Genotropin Miniquick |
| Midazolam hydrochloride 1 mg/mL, 5 mg/mL | Injection, solution | F Hoffmann-La Roche Limited, Basle, Switzerland | Hypnovel |
| Caldiamide sodium 12 mg/mL, gadodiamide 287 mg/mL | Injection, solution | Nycomed AS Production, Oslo, Norway; Nycomed Puerto Rico Inc., Barceloneta, Puerto Rico and Nycomed Ireland Limited, Carrigtwohill, County Cork, Eire | Omniscan |
| Pantoprazole sodium sesquihydrate 22.6 mg, 45.1 mg equivalent to 20 mg, 40 mg pantoprazole | Tablets, enteric coated | Byk Gulden Lomberg Chemische Fabrik GmbH., Konstanz, Germany and Oranienburger Pharmawerk GmbH., Oranienburg, Germany | Somac |
| Ondansetron 4 mg, 8 mg | Wafer | Scherer DDS Limited, Blagrove, Swindon, Wiltshire, England | Zofran Zydis |
| Goserelin acetate 3.6 mg | Implant, subcutaneous | Zeneca Pharmaceuticals, Macclesfield, Cheshire, England | Zoladex Injectable Implant |
Dated this 26th day of November 1998.
G. R. BOYD,
Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
g08567
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1998, No 196
NZLII —
NZ Gazette 1998, No 196
β¨ LLM interpretation of page content
π₯
Provisional Consent to the Distribution of a New Medicine
(continued from previous page)
π₯ Health & Social Welfare26 November 1998
Medicines Act 1981, Provisional Consent, Factor II, Factor IX, Factor X
- G. R. Boyd, Chief Advisor, Regulation and Safety
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare26 November 1998
Medicines Act 1981, Consent, Mesalazine, Metoprolol succinate, Bromhexine hydrochloride, Alendronate sodium, Ispaghula husk, Somatropin, Midazolam hydrochloride, Caldiamide sodium, Pantoprazole sodium sesquihydrate, Ondansetron, Goserelin acetate
- G. R. Boyd, Chief Advisor, Regulation and Safety
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare26 November 1998
Medicines Act 1981, Consent, Changed Medicines
- G. R. Boyd, Chief Advisor, Regulation and Safety